# Kazia Therapeutics Ltd: Form 20-F for the period ended Jun 30, 2020

- Company: [Kazia Therapeutics Ltd](/companies/kzia.md) (CIK 1075880)
- Form: 20-F
- Filed: 2020-10-22
- Accepted by EDGAR: Oct 22, 2020, 07:23 ET
- Period: 2020-06-30
- Accession: 0001193125-20-274018
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1075880/000119312520274018/d92594d20f.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1075880/000119312520274018/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2020-06-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Income tax | 12 months, 2019-07-01 to 2020-06-30 | −AUD 298.0k | ifrs-full:IncomeTaxExpenseContinuingOperations |
| Net income | 12 months, 2019-07-01 to 2020-06-30 | −AUD 12.5m | ifrs-full:ProfitLossAttributableToOwnersOfParent |
| Diluted EPS | 12 months, 2019-07-01 to 2020-06-30 | −AUD 17.07 | ifrs-full:DilutedEarningsLossPerShare |
| Basic EPS | 12 months, 2019-07-01 to 2020-06-30 | −AUD 17.07 | ifrs-full:BasicEarningsLossPerShare |
| Operating cash flow | 12 months, 2019-07-01 to 2020-06-30 | −AUD 8.8m | ifrs-full:CashFlowsFromUsedInOperatingActivities |
| Cash and equivalents | at 2020-06-30 | AUD 8.8m | ifrs-full:CashAndCashEquivalents |
| Current assets | at 2020-06-30 | AUD 10.7m | ifrs-full:CurrentAssets |
| Total assets | at 2020-06-30 | AUD 23.1m | ifrs-full:Assets |
| Current liabilities | at 2020-06-30 | AUD 5.1m | ifrs-full:CurrentLiabilities |
| Total liabilities | at 2020-06-30 | AUD 8.9m | ifrs-full:Liabilities |
| Shareholders' equity | at 2020-06-30 | AUD 14.1m | ifrs-full:EquityAttributableToOwnersOfParent |
| Shares outstanding | at 2020-06-30 | 94,598,369 shares | dei:EntityCommonStockSharesOutstanding |

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1075880/000119312520274018/d92594d20f.htm

Filed Oct 22, 2020.
Source: SEC EDGAR, the filing index for accession 0001193125-20-274018. Last ingested by Listed: Nov 2, 2026, 16:21 ET. No prices; not investment advice.
